WO2000008999A9 - Braided suture - Google Patents

Braided suture

Info

Publication number
WO2000008999A9
WO2000008999A9 PCT/IB1999/002069 IB9902069W WO0008999A9 WO 2000008999 A9 WO2000008999 A9 WO 2000008999A9 IB 9902069 W IB9902069 W IB 9902069W WO 0008999 A9 WO0008999 A9 WO 0008999A9
Authority
WO
WIPO (PCT)
Prior art keywords
suture
yarn
filaments
percent
tenacity
Prior art date
Application number
PCT/IB1999/002069
Other languages
French (fr)
Other versions
WO2000008999A3 (en
WO2000008999A2 (en
Inventor
Jeffrey D Hutton
Barry L Dumican
Original Assignee
Tyco Group Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tyco Group Sarl filed Critical Tyco Group Sarl
Priority to JP2000564507A priority Critical patent/JP4642232B2/en
Priority to DE69939461T priority patent/DE69939461D1/en
Priority to CA002321907A priority patent/CA2321907C/en
Priority to EP99959639A priority patent/EP1056389B1/en
Priority to AU16764/00A priority patent/AU1676400A/en
Publication of WO2000008999A2 publication Critical patent/WO2000008999A2/en
Publication of WO2000008999A3 publication Critical patent/WO2000008999A3/en
Publication of WO2000008999A9 publication Critical patent/WO2000008999A9/en
Priority to AU2003204676A priority patent/AU2003204676B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06At least partially resorbable materials
    • A61L17/10At least partially resorbable materials containing macromolecular materials
    • A61L17/105Polyesters not covered by A61L17/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166Sutures
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00General methods for the manufacture of artificial filaments or the like
    • D01F1/02Addition of substances to the spinning solution or to the melt
    • D01F1/06Dyes
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/62Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526Methods of manufacturing

Definitions

  • This invention relates to a process for forming a dyed braided suture.
  • Braided sutures are well known in the art as disclosed, for example in U.S. Patent No. 5,019,093.
  • Various natural and artificial polymeric materials have been used in manufacture of braided sutures, including surgical gut, silk, cotton, polyolefins, polyamides , polyglycolic acid and polyesters.
  • Braided sutures are useful in applications where a strong, nonabsorbable suture is needed to permanently repair tissue. They are frequently used in cardiovascular surgery, as well as in ophthalmic and neurological procedures.
  • polyester fibers formed from polyethylene terephthalate have been employed as suture material.
  • Such fibers have a relatively high tenacity and a relatively high intrinsic viscosity.
  • it has proven necessary to dye such fibers by boiling them in a dye soloution. Even then, there is relatively low dye penetration into the fibers.
  • To obtain thorough dye uptake by the polyester fibers it has usually proven necessary to apply dye solution at high pressure temperature to the fibers. At such elevated pressures and temperatures, however, both the dye and fiber can be degraded.
  • sutures are of great importance to surgeons. Excessive roughness affects the knot-tying and knot-holding properties of the suture, causing an uneven movement known as "chattering.” This characteristic increases the difficulty of accurately placing knots. In addition, the uneven force exerted on the suture during tying may lead to increased suture breakage.
  • sutures are coated with a lubricating material, e.g., polybutilate, to improve the handling characteristics of the sutures.
  • Figure 1 is a plan view of a system for extruding polyester filaments from bulk resin.
  • Figure 2 is a plan view of a system for drawing polyester filaments.
  • the dyed braided polyester sutures of this invention are manufactured from yarn filaments produced from thermoplastic resins having an intrinsic viscosity greater than about 0.95.
  • the polyester employed in this invention is polyethylene terephthalate (PET) .
  • PET polyethylene terephthalate
  • bulk resin in the form of granules, chips or pellets of a suitable PET are made into yarn filaments via a conventional extrusion process.
  • Bulk PET with suitable properties may be obtained commercially from, for example, Shell Chemical Co., Apple Grove, WV distributed under the designation Cleartuf EB 1040 and Traytuf 106C and DSM Engineering Plastics, Evansville, IN under the designation Arnite A06 100.
  • polyester yarn with suitable properties may be obtained commercially from, for example, Hoechst Celanese under the trade name Trevira ® High Tenacity type 712 or 787.
  • the intrinsic viscosity of such yarn samples is from 1.04 to 1.07.
  • the tenacity of the yarn filaments is from about 7.5 to about 10.5 g/denier, the percent elongation to break is less than about 25 percent and the polymers from which the fibers are made have an intrinsic viscosity greater than about 0.95 but no greater than about 1.1.
  • the tenacity of the yarn filaments is from about 8 to about 10 g/denier, the percent elongation to break is less than about 20 percent and the polymers from which the fibers are made have an intrinsic viscosity greater than about 0.95 but no greater than about 1.1.
  • the polyester yarns are made from filaments having a denier in the range from about 0.2 to about 6 , preferably from about 1.2 to about 3.4, most preferably from about 1.4 to about 3.1.
  • the polyester filaments are extruded as yarns having a denier in the range from about 20 to about 500, preferably from about 20 to about 350.
  • the yarns are generally either conventionally twisted or entangled prior to braiding.
  • twisted PET yarns can be braided into sutures using conventional braid constructions having a sheath and optionally a core.
  • Typical braid constructions are disclosed in U.S. Patent No. 5,019,093, issued May 28, 1991, the disclosure of which is incorporated herein by reference.
  • Preferred braid constructions have the parameters recited in Table 1 as follows:
  • the braids After the braids have been assembled, they are preferably stretched in the presence of heat. Preferably, the temperature range for such stretching is from about 150°C to about 250°C.
  • length of the braided sutures increases by about 6% to about 33% of their original length.
  • the surface of the stretched braids can sometimes be unduly smooth after such treatment. An unduly smooth suture surface can make it difficult to grasp the suture and tie a desired knot. Also, stretching can greatly stiffen the braid imparting undesirable handling properties to the suture. In order to allow better control of the suture during tying it is preferred to conduct additional processing of the suture to provide appropriate surface roughness and lessen fiber stiffness to allow the surgeon to have better feel of the suture and permit easier knotting.
  • the stretched braid may be surface-etched to break any adhesions present on the braid surface and to soften the braid.
  • etching is conducted by applying a reactive compound such as sodium hydroxide or the like to the surface of the braid.
  • the braid can be passed under a matte roller or the like. The surface etching and matte roller treatments can further improve the surface feel of the braid to facilitate knot tying.
  • the braided polyester sutures are treated with a coating material to impart improved handling to the treated braid.
  • the preferred coating material is silastic rubber.
  • the braid is then formed into a suture by attaching a needle, packaging the product and then sterilizing with ionizing radiation, ethylene oxide or the like.
  • the filaments in the final suture product may have a molecular weight less than the molecular weight of the original polymer. It is believed that the sterilizing treatment, heating and/or stretching treatments conducted during processing of the filaments into a suture may break polymer chains and reduce molecular weight.
  • the improved sutures of this invention as compared to commercially available sutures, have significantly improved tensile strength.
  • the polyester yarns are used in providing an i plantable medical device.
  • a mesh, a graft, a ligament replacement and a tendon replacement is typically used in surgical repair of hernias.
  • the enhanced tenacity of the polyester yarns of this invention provides the mesh with superior strength.
  • a graft is a knitted or woven tubular article used in replacement of blood vessels.
  • the enhanced tenacity of the polyester yarns of this invention allows construction of a graft with thinner walls and greater flexibility.
  • Ligament and tendon replacements comprise multiple strands of polyester yarns that have been braided, for which the yarns of the present invention provide superior strength.
  • a braided suture is formed from yarn filaments having a weight average molecular weight of greater than 35,000, a tenacity of greater than about 6 grams/denier, an elongation to break less than about 35% and a boiling water shrinkage from about 0.5 to about 2.0%.
  • the filaments have a weight average molecular weight preferably greater than 40,000 and, most preferably, from about 42,000 to 45,000.
  • the tenacity of the filaments is preferably greater than 7 grams/denier and most preferably from about 7 grams/denier to about 8.5 grams/denier.
  • the percent elongation to break is preferably less than 25%, most preferably less than 20%.
  • the filaments may have a hot air shrinkage at 350°C from about 3 to 5% of the original length.
  • the filaments are typically extruded in bundles (yarns) havinging a denier from about 20 to about 500 and preferably are twisted to about 4-15 turns per inch.
  • the twisted yarns are braided into sutures using conventional braid construction having a sheath and, optionally, a core according to, for example, U.S. Patent No. 5,019,093.
  • a spiral braid pattern may be used as described in U.S. Patent No. 4,959,069 and U.S. Patent No. 5,059,213.
  • the braided suture may be stretched as before to increase length from about 9 to 28% over initial length.
  • An absorbable or nonabsorbable coating can also be applied.
  • the stretched braid can be surface-etched and/or matte rolled. A needle is thereafter attached, the suture packaged and the product is sterilized.
  • the molecular weight of the filaments in the sterilized suture may be significantly less than that of the original filaments since processing and sterilization can break polymer chains.
  • a PET yarn extrusion system employed in the invention is illustrated in Figure 1.
  • Bulk PET resin (type TTF 1006C, available from Shell Chemical Co.) having an intrinsic viscosity of 1.04 was dried overnight in an oven at 110-130°C under a vacuum of less than 2 Torr. The oven was brought to atmospheric pressure with dry air.
  • the dried resin was transferred to feed hopper 10 of the extrusion system and introduced into extruder barrel 20 which is 0.75 inches in diameter and 15 inches long via an extrusion screw (not shown) .
  • the extruder barrel contained three heating zones (or extrusion zones) - zones 1, 2 and 3.
  • the heated and softened resin from the extruder was fed into a metering pump (melt pump) 25, and from melt pump 25 the extruded resin was fed into spin head 30.
  • Spin head 30 houses a spin pack comprising filtering media (screens) and a spinnerette containing from 16 to 35 holes (not shown) for forming the individual filaments of the yarn.
  • the extruded filaments 50 exited the spinnerette through hot collar 40, and were then air-cooled until they solidified.
  • the resulting yarn was then passed through a finish applicator 60, over two rotating godets 70 and 80, and was collected on precision winder 90 as the yarn exited the second godet 80.
  • the denier of the yarn at this point was 354.
  • Example 1 After a six-day lag time the yarn extruded in Example 1 was drawn. Drawing was conducted by passing the extruded yarn 100 around multiple rotating rolls, as illustrated in Figure 2. The drawing action was initiated by passing yarn 100 first over a roll (godet) 110 having a first, lower rotational speed and then over godets 120 and 130 having successively higher rotational speeds. Drawing occurred predominantly between godet 120 and godet 130 and was facilitated by heating the godets. The drawn yarn was entangled in air jet entangler 140 and then wound onto precision winder 150. The yarn drawing conditions are shown in Table 3.
  • the drawn yarn produced in Example 2 was formed into a suture as follows: Yarn samples were plied at 3 turns per inch and then braided on a New England Butt 8 carrier braider (not shown) at 38.6 picks per inch. The braid was then hot stretched in a tunnel between opposed matte surfaced godets numbered (1) and (2) under the conditions shown in Table 5. The braid was stretched 21%.
  • the stretched braid was softened by treatment in 3% NaOH aqueous solution maintained at 82.2°C for 30 minutes. The softened braid was then washed and rinsed. The washed braid was then immersed in a solution of 5% silastic rubber and benzoyl peroxide as actives in a xylene solvent to coat the braid. The silastic rubber-coated braid was next cured in an oven at 170°C and converted into a suture by attaching a needle, packaging and finally sterilizing with ethylene oxide. The properties of the suture were as in Table 6. Table 6
  • Tenacity was determined by a straight pull of a sample using a 10 inch gauge length and 10 inch per minute crosshead speed. "Cord and yarn” clamps were used for this purpose.
  • Knot pull was determined by tying a sample in a "surgeon's knot" around a piece of rubber tubing and testing as in determining tenacity.
  • the suture had an excellent feel, did not exhibit "chattering" during use and provided reduced tendency to break during knot tying.
  • Fiber was taken up on precision winder 90 as it exited second godet 80.
  • the denier of the yarn at this point was 341.
  • Example 4 After a lag time of three (3) days, the extruded yarn of Example 4 was drawn as described in Example 2, using the drawing conditions shown in Table 8. Table 8
  • Drawn fiber was taken up on precision winder 150 as it exited godet 130.
  • the properties of the drawn fiber are shown in Table 9.
  • Example 5 The drawn yarn produced in Example 5 was converted to a suture as follows: Yarn samples were two plied at 3 turns per inch and then braided on a New England Butt 8 carrier braider. The braid was then hot stretched under the conditions shown in Table 10 to stretch the braid 33%. Table 10
  • the stretched braids were softened and coated as described in Example 3.
  • the properties of the finished braids are shown in Table 11.

Abstract

A braided polyester suture made from polyester yarn filaments having a tenacity of from about 7 to about 11 g/denier, a percent elongation to break of less than about 30 percent and the polymer from which the filaments are made has an intrinsic viscosity greater than about 0.95. The invention also provides an implantable medical device constructed from yarn filaments having these properties.

Description

TITLE
BRAIDED SUTURE
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates to a process for forming a dyed braided suture.
Related Background Art
Braided sutures are well known in the art as disclosed, for example in U.S. Patent No. 5,019,093. Various natural and artificial polymeric materials have been used in manufacture of braided sutures, including surgical gut, silk, cotton, polyolefins, polyamides , polyglycolic acid and polyesters. Braided sutures are useful in applications where a strong, nonabsorbable suture is needed to permanently repair tissue. They are frequently used in cardiovascular surgery, as well as in ophthalmic and neurological procedures.
For various reasons it is desirable to provide sutures which are dyed to allow immediate suture brand and or type recognition by the surgical team or treating physician . Previously, braided yarns were formed from polymer filaments and then solution dyed. The braids were at a lower tenacity than the final product because it is easier to dye a less crystalline yarn. Thereafter, the dyed braids were stretched to increase tenacity by making the yarn more crystalline. However, braided yarns are not dyed thoroughly by conventional solution dyeing techniques even at a lower tenacity prior to stretching. The braided yarns resist uniform penetration by dye solutions.
Recently, higher molecular weight polyester fibers formed from polyethylene terephthalate have been employed as suture material. Such fibers have a relatively high tenacity and a relatively high intrinsic viscosity. However, it has proven necessary to dye such fibers by boiling them in a dye soloution. Even then, there is relatively low dye penetration into the fibers. To obtain thorough dye uptake by the polyester fibers it has usually proven necessary to apply dye solution at high pressure temperature to the fibers. At such elevated pressures and temperatures, however, both the dye and fiber can be degraded.
Accordingly, it is desired to provide a method for incorporating dye uniformly into a suture material free of the defects and deficiencies of the prior art.
These and other objects and advantages are achieved by forming a dyed braided suture by:
(a) blending a biocompatible colorant with an extrudable non-broad desirable thermoplastic resin to form a uniform blend of said colorant resin;
(b) extruding the blend by melt spinning and colling to form filaments;
(c) drawing the filaments to increase crystallinity and moleuclar orientation; (d) braiding the filaments; and
(e) converting the braided filaments into a suture.
The surface roughness of braided sutures is of great importance to surgeons. Excessive roughness affects the knot-tying and knot-holding properties of the suture, causing an uneven movement known as "chattering." This characteristic increases the difficulty of accurately placing knots. In addition, the uneven force exerted on the suture during tying may lead to increased suture breakage. Typically, sutures are coated with a lubricating material, e.g., polybutilate, to improve the handling characteristics of the sutures.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a plan view of a system for extruding polyester filaments from bulk resin.
Figure 2 is a plan view of a system for drawing polyester filaments.
DETAILED DESCRIPTION OF THE INVENTION
The dyed braided polyester sutures of this invention are manufactured from yarn filaments produced from thermoplastic resins having an intrinsic viscosity greater than about 0.95.
pickup a
Preferably, the polyester employed in this invention is polyethylene terephthalate (PET) . If desired, bulk resin in the form of granules, chips or pellets of a suitable PET are made into yarn filaments via a conventional extrusion process. Bulk PET with suitable properties may be obtained commercially from, for example, Shell Chemical Co., Apple Grove, WV distributed under the designation Cleartuf EB 1040 and Traytuf 106C and DSM Engineering Plastics, Evansville, IN under the designation Arnite A06 100.
Alternatively, polyester yarn with suitable properties may be obtained commercially from, for example, Hoechst Celanese under the trade name Trevira® High Tenacity type 712 or 787. The intrinsic viscosity of such yarn samples is from 1.04 to 1.07.
Preferably, the tenacity of the yarn filaments is from about 7.5 to about 10.5 g/denier, the percent elongation to break is less than about 25 percent and the polymers from which the fibers are made have an intrinsic viscosity greater than about 0.95 but no greater than about 1.1.
Most preferably, the tenacity of the yarn filaments is from about 8 to about 10 g/denier, the percent elongation to break is less than about 20 percent and the polymers from which the fibers are made have an intrinsic viscosity greater than about 0.95 but no greater than about 1.1.
The polyester yarns are made from filaments having a denier in the range from about 0.2 to about 6 , preferably from about 1.2 to about 3.4, most preferably from about 1.4 to about 3.1. The polyester filaments are extruded as yarns having a denier in the range from about 20 to about 500, preferably from about 20 to about 350. The yarns are generally either conventionally twisted or entangled prior to braiding. In one embodiment twisted PET yarns can be braided into sutures using conventional braid constructions having a sheath and optionally a core. Typical braid constructions are disclosed in U.S. Patent No. 5,019,093, issued May 28, 1991, the disclosure of which is incorporated herein by reference. Preferred braid constructions have the parameters recited in Table 1 as follows:
Table 1: Preferred Braid Constructions
Figure imgf000007_0001
After the braids have been assembled, they are preferably stretched in the presence of heat. Preferably, the temperature range for such stretching is from about 150°C to about 250°C. Typically, length of the braided sutures increases by about 6% to about 33% of their original length. The surface of the stretched braids can sometimes be unduly smooth after such treatment. An unduly smooth suture surface can make it difficult to grasp the suture and tie a desired knot. Also, stretching can greatly stiffen the braid imparting undesirable handling properties to the suture. In order to allow better control of the suture during tying it is preferred to conduct additional processing of the suture to provide appropriate surface roughness and lessen fiber stiffness to allow the surgeon to have better feel of the suture and permit easier knotting.
To further enhance the feel of the suture, the stretched braid may be surface-etched to break any adhesions present on the braid surface and to soften the braid. Such etching is conducted by applying a reactive compound such as sodium hydroxide or the like to the surface of the braid. To further control the feel of the suture surface, the braid can be passed under a matte roller or the like. The surface etching and matte roller treatments can further improve the surface feel of the braid to facilitate knot tying.
Optionally, the braided polyester sutures are treated with a coating material to impart improved handling to the treated braid. The preferred coating material is silastic rubber.
The braid is then formed into a suture by attaching a needle, packaging the product and then sterilizing with ionizing radiation, ethylene oxide or the like.
The filaments in the final suture product may have a molecular weight less than the molecular weight of the original polymer. It is believed that the sterilizing treatment, heating and/or stretching treatments conducted during processing of the filaments into a suture may break polymer chains and reduce molecular weight.
The improved sutures of this invention, as compared to commercially available sutures, have significantly improved tensile strength.
In another embodiment of this invention, the polyester yarns are used in providing an i plantable medical device. Examples of such a device is a mesh, a graft, a ligament replacement and a tendon replacement. A mesh, or net formed from polyester yarns is typically used in surgical repair of hernias. The enhanced tenacity of the polyester yarns of this invention provides the mesh with superior strength. A graft is a knitted or woven tubular article used in replacement of blood vessels. The enhanced tenacity of the polyester yarns of this invention allows construction of a graft with thinner walls and greater flexibility. Ligament and tendon replacements comprise multiple strands of polyester yarns that have been braided, for which the yarns of the present invention provide superior strength.
In a further embodiment of the invention a braided suture is formed from yarn filaments having a weight average molecular weight of greater than 35,000, a tenacity of greater than about 6 grams/denier, an elongation to break less than about 35% and a boiling water shrinkage from about 0.5 to about 2.0%. In this embodiment the filaments have a weight average molecular weight preferably greater than 40,000 and, most preferably, from about 42,000 to 45,000. The tenacity of the filaments is preferably greater than 7 grams/denier and most preferably from about 7 grams/denier to about 8.5 grams/denier. The percent elongation to break is preferably less than 25%, most preferably less than 20%. The filaments may have a hot air shrinkage at 350°C from about 3 to 5% of the original length.
The filaments are typically extruded in bundles (yarns) havinging a denier from about 20 to about 500 and preferably are twisted to about 4-15 turns per inch. The twisted yarns are braided into sutures using conventional braid construction having a sheath and, optionally, a core according to, for example, U.S. Patent No. 5,019,093. Alternatively, a spiral braid pattern may be used as described in U.S. Patent No. 4,959,069 and U.S. Patent No. 5,059,213. The braided suture may be stretched as before to increase length from about 9 to 28% over initial length. An absorbable or nonabsorbable coating can also be applied.
If desired to further enhance surface feel the stretched braid can be surface-etched and/or matte rolled. A needle is thereafter attached, the suture packaged and the product is sterilized.
The molecular weight of the filaments in the sterilized suture may be significantly less than that of the original filaments since processing and sterilization can break polymer chains.
The examples which follow are intended to illustrate certain preferred embodiments of the invention, and no limitation of the invention is implied.
EXAMPLE 1 Extrusion of PET Yarns
A PET yarn extrusion system employed in the invention is illustrated in Figure 1. Bulk PET resin (type TTF 1006C, available from Shell Chemical Co.) having an intrinsic viscosity of 1.04 was dried overnight in an oven at 110-130°C under a vacuum of less than 2 Torr. The oven was brought to atmospheric pressure with dry air. The dried resin was transferred to feed hopper 10 of the extrusion system and introduced into extruder barrel 20 which is 0.75 inches in diameter and 15 inches long via an extrusion screw (not shown) . The extruder barrel contained three heating zones (or extrusion zones) - zones 1, 2 and 3. The heated and softened resin from the extruder was fed into a metering pump (melt pump) 25, and from melt pump 25 the extruded resin was fed into spin head 30.
Spin head 30 houses a spin pack comprising filtering media (screens) and a spinnerette containing from 16 to 35 holes (not shown) for forming the individual filaments of the yarn. The extruded filaments 50 exited the spinnerette through hot collar 40, and were then air-cooled until they solidified. The resulting yarn was then passed through a finish applicator 60, over two rotating godets 70 and 80, and was collected on precision winder 90 as the yarn exited the second godet 80. The denier of the yarn at this point was 354.
The operating parameters for the extrusion system are shown in Table 2. Table 2
Figure imgf000012_0001
EXAMPLE 2 Drawing of Yarn Extruded in Example 1
After a six-day lag time the yarn extruded in Example 1 was drawn. Drawing was conducted by passing the extruded yarn 100 around multiple rotating rolls, as illustrated in Figure 2. The drawing action was initiated by passing yarn 100 first over a roll (godet) 110 having a first, lower rotational speed and then over godets 120 and 130 having successively higher rotational speeds. Drawing occurred predominantly between godet 120 and godet 130 and was facilitated by heating the godets. The drawn yarn was entangled in air jet entangler 140 and then wound onto precision winder 150. The yarn drawing conditions are shown in Table 3.
Table 3
Figure imgf000013_0001
Properties of the drawn fiber were measured on an Instron Tensile Tester, Model 1130, equipped with cord and yarn clamps. The initial specimen length was 10 inches and the test was run at 10 inches of extension per minute. The results were as shown in Table 4.
Table 4
Figure imgf000013_0002
EXAMPLE 3 Braided Polyester Sutures
The drawn yarn produced in Example 2 was formed into a suture as follows: Yarn samples were plied at 3 turns per inch and then braided on a New England Butt 8 carrier braider (not shown) at 38.6 picks per inch. The braid was then hot stretched in a tunnel between opposed matte surfaced godets numbered (1) and (2) under the conditions shown in Table 5. The braid was stretched 21%.
Table 5
Figure imgf000014_0001
The stretched braid was softened by treatment in 3% NaOH aqueous solution maintained at 82.2°C for 30 minutes. The softened braid was then washed and rinsed. The washed braid was then immersed in a solution of 5% silastic rubber and benzoyl peroxide as actives in a xylene solvent to coat the braid. The silastic rubber-coated braid was next cured in an oven at 170°C and converted into a suture by attaching a needle, packaging and finally sterilizing with ethylene oxide. The properties of the suture were as in Table 6. Table 6
Figure imgf000015_0001
(7) Tenacity was determined by a straight pull of a sample using a 10 inch gauge length and 10 inch per minute crosshead speed. "Cord and yarn" clamps were used for this purpose.
(?) Knot pull was determined by tying a sample in a "surgeon's knot" around a piece of rubber tubing and testing as in determining tenacity.
The suture had an excellent feel, did not exhibit "chattering" during use and provided reduced tendency to break during knot tying.
EXAMPLE 4 Extrusion of PET Yarn
Bulk PET, sold as Arnite A06 100 and available from DSM Engineering Plastics, having an intrinsic viscosity of 1.07 (tetrachloroethoxyphenol) was processed as described in Example 1 under the operating parameters shown in Table 7 as follows: Table 7
Figure imgf000016_0001
Fiber was taken up on precision winder 90 as it exited second godet 80. The denier of the yarn at this point was 341.
EXAMPLE 5 Drawing of Extruded Yarn of Example 4
After a lag time of three (3) days, the extruded yarn of Example 4 was drawn as described in Example 2, using the drawing conditions shown in Table 8. Table 8
Figure imgf000017_0001
Drawn fiber was taken up on precision winder 150 as it exited godet 130. The properties of the drawn fiber are shown in Table 9.
Table 9
Figure imgf000017_0002
EXAMPLE 6 Braided Polyester Sutures
The drawn yarn produced in Example 5 was converted to a suture as follows: Yarn samples were two plied at 3 turns per inch and then braided on a New England Butt 8 carrier braider. The braid was then hot stretched under the conditions shown in Table 10 to stretch the braid 33%. Table 10
Figure imgf000018_0001
The stretched braids were softened and coated as described in Example 3. The properties of the finished braids are shown in Table 11.
Table 11
Figure imgf000018_0002
Other variations and modifications of this invention will be obvious to those skilled in the art. This invention is not limited except as set forth in the following claims.

Claims

WHAT IS CLAIMED IS:
1. A braided polyester suture produced from a polymer having an intrinsic viscosity greater than about 0.95 and formed from yarn filaments having (i) a tenacity of from about 7 to about 11 g/denier and (ii) a percent elongation to break of less than about 30 percent.
2. The braided polyester suture of claim 1, wherein the braided suture has the following construction:
Figure imgf000019_0001
3. The braided polyester suture of claim 2 , wherein the yarn filaments have a tenacity of from about 7.5 to about 10.5 g/denier, a percent elongation to break of less than about 25 percent when produced from a polymer having an intrinsic viscosity greater than about 0.95 but no greater than about 1.1.
4. The braided polyester suture of claim 3 , wherein the yarn filaments have a tenacity of from about 8 to about 10 g/denier and a percent elongation to break of less than about 20 percent.
5. An implantable medical device produced from a polymer having an intrinsic viscosity greater than about 0.95 and formed from yarn filaments having a tenacity of from about 7 to about 11 g/denier and a percent elongation to break of less than about 30 percent.
6. The implantable medical device of claim 5, wherein said implantable medical device is selected from the group consisting of a mesh, a graft, a ligament replacement and a tendon replacement.
7. The implantable medical device of claim 6, wherein the yarn filaments have a tenacity of from about 7.5 to about 10.5 g/denier, a percent elongation to break of less than about 25 percent when produced from a polymer having an intrinsic viscosity greater than about 0.95 but no greater than about 1.1.
8. The implantable medical device of claim 7 , wherein the yarn filaments have a tenacity of from about 8 to about 10 g/denier and a percent elongation to break of less than about 20 percent.
PCT/IB1999/002069 1998-02-26 1999-02-26 Braided suture WO2000008999A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2000564507A JP4642232B2 (en) 1998-02-26 1999-02-26 Method for forming dyed knitted suture
DE69939461T DE69939461D1 (en) 1998-02-26 1999-02-26 BRAIDED SEWING MATERIAL
CA002321907A CA2321907C (en) 1998-02-26 1999-02-26 Braided suture
EP99959639A EP1056389B1 (en) 1998-02-26 1999-02-26 Braided suture
AU16764/00A AU1676400A (en) 1998-02-26 1999-02-26 Process for forming dyed braided suture
AU2003204676A AU2003204676B2 (en) 1998-02-26 2003-06-13 Process for Forming Dyed Braided Suture

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/030,868 1998-02-26
US09/030,868 US6203564B1 (en) 1998-02-26 1998-02-26 Braided polyester suture and implantable medical device

Publications (3)

Publication Number Publication Date
WO2000008999A2 WO2000008999A2 (en) 2000-02-24
WO2000008999A3 WO2000008999A3 (en) 2000-07-06
WO2000008999A9 true WO2000008999A9 (en) 2000-08-10

Family

ID=21856433

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB1999/002069 WO2000008999A2 (en) 1998-02-26 1999-02-26 Braided suture

Country Status (8)

Country Link
US (1) US6203564B1 (en)
EP (1) EP1056389B1 (en)
JP (1) JP4642232B2 (en)
AU (1) AU1676400A (en)
CA (1) CA2321907C (en)
DE (1) DE69939461D1 (en)
ES (1) ES2313798T3 (en)
WO (1) WO2000008999A2 (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100016891A1 (en) 2003-08-14 2010-01-21 Kennedy John J Heterogeneous yarns for surgical articles
US20050125036A1 (en) 2003-08-14 2005-06-09 Mark Roby Heterogeneous yarns for surgical articles
US20050149093A1 (en) * 2003-10-30 2005-07-07 Pokorney James L. Valve bypass graft device, tools, and method
US20050119696A1 (en) * 2003-12-02 2005-06-02 Walters Troy M. Braided suture
US8263105B2 (en) 2004-12-01 2012-09-11 Tyco Healthcare Group Lp Biomaterial drug delivery and surface modification compositions
US7559952B2 (en) * 2004-12-17 2009-07-14 Innovia, Llc Elastomeric polymer filament cosmetic implant
US20060212072A1 (en) * 2005-03-16 2006-09-21 Cuevas Brian J Polyolefin sutures having enhanced durability
AU2006202432B2 (en) 2005-07-11 2012-05-17 Covidien Lp Antimicrobial sutures and methods of making them
US20070205910A1 (en) * 2006-02-22 2007-09-06 Parker-Hannifin Corporation Wireless motion control system
EP1993520A4 (en) * 2006-02-28 2012-10-31 Tyco Healthcare Antimicrobial medical devices
EP1991240A4 (en) * 2006-02-28 2012-12-12 Tyco Healthcare Antimicrobial releasing polymers
ES2329092T3 (en) 2006-09-06 2009-11-20 Tyco Healthcare Group, Lp PUAS SUTURES.
US8348973B2 (en) * 2006-09-06 2013-01-08 Covidien Lp Bioactive substance in a barbed suture
US20100092530A1 (en) 2006-09-20 2010-04-15 Stopek Joshua B Novel Triclosan Salts
US8353931B2 (en) 2006-11-02 2013-01-15 Covidien Lp Long term bioabsorbable barbed sutures
US20080132943A1 (en) 2006-12-05 2008-06-05 Nicholas Maiorino Knotless wound closure device
US20100323961A1 (en) 2007-02-09 2010-12-23 Tyco Healthcare Group Lp Surface eroding sutures
US20080195147A1 (en) * 2007-02-09 2008-08-14 Tyco Healthcare Group Lp Surface eroding barbed sutures
JP2010527401A (en) 2007-05-14 2010-08-12 タイコ ヘルスケア グループ リミテッド パートナーシップ Antibacterial materials and coatings
WO2008141835A1 (en) * 2007-05-23 2008-11-27 Dsm Ip Assets B.V. Colored suture
US20090048423A1 (en) * 2007-08-15 2009-02-19 Tyco Healthcare Group Lp Phospholipid Copolymers
US8268958B2 (en) * 2007-08-15 2012-09-18 Tyco Healthcare Group Ip Phospholipid copolymers
US20090112236A1 (en) 2007-10-29 2009-04-30 Tyco Healthcare Group Lp Filament-Reinforced Composite Fiber
US8888810B2 (en) 2008-02-20 2014-11-18 Covidien Lp Compound barb medical device and method
US8454653B2 (en) 2008-02-20 2013-06-04 Covidien Lp Compound barb medical device and method
US8273105B2 (en) 2008-02-20 2012-09-25 Tyco Healthcare Group Lp Compound barb medical device and method
US8932327B2 (en) * 2008-04-01 2015-01-13 Covidien Lp Anchoring device
US10376261B2 (en) 2008-04-01 2019-08-13 Covidien Lp Anchoring suture
US9034011B2 (en) * 2008-04-01 2015-05-19 Covidien Lp Anchoring device
US9358002B2 (en) 2008-04-01 2016-06-07 Covidien Lp Anchoring device
US20100228270A1 (en) 2008-04-11 2010-09-09 Michael Bogart Deployment System for Surgical Suture
US20090264925A1 (en) 2008-04-17 2009-10-22 Joseph Hotter Poly(Trimethylene)Terephthalate Filaments And Articles Made Therefrom
US20100204729A1 (en) 2008-09-11 2010-08-12 Ahmad Robert Hadba Tapered Looped Suture
US8323316B2 (en) 2008-10-09 2012-12-04 Covidien Lp Knotted suture end effector
US20100094338A1 (en) * 2008-10-15 2010-04-15 Tyco Healthcare Group Lp Hydroxamate-initiated polymers
US20100094340A1 (en) * 2008-10-15 2010-04-15 Tyco Healthcare Group Lp Coating compositions
US7923439B2 (en) * 2008-10-15 2011-04-12 Tyco Healthcare Group Lp Hydroxamate compositions
CN102271603A (en) 2008-11-17 2011-12-07 明诺医学股份有限公司 Selective accumulation of energy with or without knowledge of tissue topography
US20110082499A1 (en) 2009-10-05 2011-04-07 Tyco Healthcare Group Lp Coatings that enhance resistance to abrasion
US20110082500A1 (en) 2009-10-05 2011-04-07 Tyco Healthcare Group Lp Coatings that enhance resistance to abrasion
US9044224B2 (en) 2010-04-12 2015-06-02 Covidien Lp Barbed medical device and method
US8303881B2 (en) 2010-10-28 2012-11-06 Covidien Lp Suture containing barbs
US8414612B2 (en) 2010-11-08 2013-04-09 Covidien Lp Multifilament barbed suture
US8998059B2 (en) 2011-08-01 2015-04-07 Ethicon Endo-Surgery, Inc. Adjunct therapy device having driver with cavity for hemostatic agent
US9492170B2 (en) 2011-08-10 2016-11-15 Ethicon Endo-Surgery, Inc. Device for applying adjunct in endoscopic procedure
US8998060B2 (en) 2011-09-13 2015-04-07 Ethicon Endo-Surgery, Inc. Resistive heated surgical staple cartridge with phase change sealant
US9101359B2 (en) 2011-09-13 2015-08-11 Ethicon Endo-Surgery, Inc. Surgical staple cartridge with self-dispensing staple buttress
US9999408B2 (en) 2011-09-14 2018-06-19 Ethicon Endo-Surgery, Inc. Surgical instrument with fluid fillable buttress
US9254180B2 (en) 2011-09-15 2016-02-09 Ethicon Endo-Surgery, Inc. Surgical instrument with staple reinforcement clip
US8814025B2 (en) 2011-09-15 2014-08-26 Ethicon Endo-Surgery, Inc. Fibrin pad matrix with suspended heat activated beads of adhesive
US9125649B2 (en) 2011-09-15 2015-09-08 Ethicon Endo-Surgery, Inc. Surgical instrument with filled staple
US9198644B2 (en) 2011-09-22 2015-12-01 Ethicon Endo-Surgery, Inc. Anvil cartridge for surgical fastening device
US9393018B2 (en) 2011-09-22 2016-07-19 Ethicon Endo-Surgery, Inc. Surgical staple assembly with hemostatic feature
US8985429B2 (en) 2011-09-23 2015-03-24 Ethicon Endo-Surgery, Inc. Surgical stapling device with adjunct material application feature
US8899464B2 (en) 2011-10-03 2014-12-02 Ethicon Endo-Surgery, Inc. Attachment of surgical staple buttress to cartridge
US9089326B2 (en) 2011-10-07 2015-07-28 Ethicon Endo-Surgery, Inc. Dual staple cartridge for surgical stapler
US20150328062A9 (en) 2011-11-10 2015-11-19 Covidien Lp Hydrophilic medical devices
US20130123816A1 (en) 2011-11-10 2013-05-16 Gerald Hodgkinson Hydrophilic medical devices
US9220492B2 (en) 2012-02-01 2015-12-29 Covidien Lp Wound closure device
US9107660B2 (en) 2012-02-01 2015-08-18 Covidien Lp Wound closure device
JP6261909B2 (en) * 2013-08-26 2018-01-17 松田医科工業株式会社 Suture and manufacturing method thereof
US9700311B2 (en) 2013-11-08 2017-07-11 Ethicon Llc Tissue ingrowth materials and method of using the same
IL300213B1 (en) 2014-11-04 2024-02-01 Surgical Specialties Corp Braided suture coat
US10549208B1 (en) * 2017-09-01 2020-02-04 Gerald R. Herren Portable balloon tying device
US11272924B2 (en) 2018-07-18 2022-03-15 Arthrex, Inc. Knotless closure sutures and methods of tissue fixation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465319A (en) 1941-07-29 1949-03-22 Du Pont Polymeric linear terephthalic esters
US3322125A (en) 1966-04-04 1967-05-30 Sutures Inc Sutures and method of making same
US3565077A (en) * 1968-05-06 1971-02-23 American Cyanamid Co Densified absorbably polyglycolic acid suture braid, and method for preparing same
US4149277A (en) 1977-06-22 1979-04-17 General Atomic Company Artificial tendon prostheses
US4470941A (en) 1982-06-02 1984-09-11 Bioresearch Inc. Preparation of composite surgical sutures
US4510934A (en) 1983-05-13 1985-04-16 Batra Subhash K Suture
US5306289A (en) * 1987-08-26 1994-04-26 United States Surgical Corporation Braided suture of improved characteristics
US5261886A (en) 1987-08-26 1993-11-16 United States Surgical Corporation Cabled core and braided suture made therefrom
US5019093A (en) 1989-04-28 1991-05-28 United States Surgical Corporation Braided suture
JPH01223969A (en) 1988-03-04 1989-09-07 Nippon Medical Supply Corp Coated suture
JPH0261109A (en) * 1988-08-23 1990-03-01 Unitika Ltd Polyester fiber
CA1337498C (en) 1989-09-01 1995-11-07 Ephraim Broyer Thermal treatment of thermoplastic filaments
US4959069A (en) 1989-10-20 1990-09-25 Ethicon, Inc. Braided surgical sutures
US5181923A (en) * 1990-03-26 1993-01-26 United States Surgical Corporation Spiroid braided suture
US5059213A (en) 1990-03-26 1991-10-22 United States Surgical Corporation Spiroid braided suture
US5318575A (en) 1992-02-03 1994-06-07 United States Surgical Corporation Method of using a surgical repair suture product
CA2108603A1 (en) * 1992-10-23 1994-04-24 Michael P. Chesterfield Surgical repair product
US5688451A (en) * 1995-01-03 1997-11-18 American Cyanamid Company Method of forming an absorbable biocompatible suture yarn
AU5947096A (en) * 1995-07-26 1997-01-30 Ethicon Inc. Braided polyester suture

Also Published As

Publication number Publication date
JP2002522144A (en) 2002-07-23
JP4642232B2 (en) 2011-03-02
US6203564B1 (en) 2001-03-20
EP1056389A2 (en) 2000-12-06
EP1056389B1 (en) 2008-09-03
DE69939461D1 (en) 2008-10-16
AU1676400A (en) 2000-03-06
ES2313798T3 (en) 2009-03-01
CA2321907A1 (en) 2000-02-24
CA2321907C (en) 2007-07-03
WO2000008999A3 (en) 2000-07-06
WO2000008999A2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
CA2321907C (en) Braided suture
US6045571A (en) Multifilament surgical cord
JP4354031B2 (en) Braided suture with improved knot strength and method for manufacturing the same
JP4959045B2 (en) Surgical filament structure
US6063105A (en) Medical devices fabricated from elastomeric alpha-olefins
WO1986000020A1 (en) Composite surgical sutures
CA2080500A1 (en) Jet entangled suture yarn and method for making same
US6005019A (en) Plasticizers for fibers used to form surgical devices
US5585056A (en) Plasticizers for fibers used to form surgical devices
JP3556681B2 (en) Sterilized two-component fiber braid
US4932404A (en) Chitin fibers and process for the production of the same
US5797962A (en) Surgical suture and method for preparation thereof
US5688451A (en) Method of forming an absorbable biocompatible suture yarn
US5571469A (en) Process for producing a polyamide suture
US5587122A (en) In-line annealing of sutures
US6060007A (en) Process for forming dyed braided suture
AU2003204676B2 (en) Process for Forming Dyed Braided Suture
KR20040002673A (en) Process for the formation of high strength bio-absorbable suture fibers and the suture produced thereby
KR100946757B1 (en) Absorbable multi-filament suture having excellent tenacity and in-vivo breaking strength retention, and method of preparing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 16764

Kind code of ref document: A

Format of ref document f/p: F

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGE 1, DESCRIPTION, REPLACED BY A NEW PAGE 1; PAGES 1/2-2/2, DRAWINGS, REPLACED BY NEW PAGES 1/2-2/2 (WITH AN UPDATED VERSION OF THE PAMPHLET FRONT PAGE)

ENP Entry into the national phase

Ref document number: 2321907

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 16764/00

Country of ref document: AU

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999959639

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999959639

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 1999959639

Country of ref document: EP